Welcome, everybody. I would like to bring the meeting to order.
Welcome to our guests who are here today. We have with us the Cancer Advocacy Coalition of Canada, the Expert Advisory Committee on the Vigilance of Health Products, the Institute for Safe Medication Practices Canada, and representation from the University of Montreal.
Pursuant to Standing Order 108(2), I'd like to welcome you all to the seventh meeting of the post-market surveillance of pharmaceutical products, prescriptions, and non-prescriptions.
I'm going to ask the witnesses to give a 10-minute presentation. After all the presentations are finished, we'll get the questions from the committee.
We're very grateful that you took the time to join us this morning, and we're eagerly listening to all the insightful information that each one of you will tell us. Could we please begin with the Cancer Advocacy Coalition of Canada?